Related references
Note: Only part of the references are listed.IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
Joshua Bennett et al.
CURRENT OPINION IN HEMATOLOGY (2022)
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
Thomas A. Burley et al.
CANCERS (2022)
NF-?B: blending metabolism, immunity, and inflammation
Daria Capece et al.
TRENDS IN IMMUNOLOGY (2022)
In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing
Eva Hoferkova et al.
CANCERS (2022)
Macrophage- and BCR- but not TLR-derived signals support the growth of CLL and Richter Syndrome murine models in vivo
Claudio Martines et al.
BLOOD (2022)
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint
TingTing Tang et al.
PHARMACOLOGY & THERAPEUTICS (2021)
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target
Emma Kennedy et al.
BLOOD (2021)
Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments
Stefania Fiorcari et al.
CELLS (2021)
Targeting the tumor microenvironment in chronic lymphocytic leukemia
Rebecka Svanberg et al.
HAEMATOLOGICA (2021)
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib
Veronika Sandova et al.
HAEMATOLOGICA (2021)
Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations-NOTCH1, SF3B1, MYD88, BIRC3
Maciej Putowski et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia
Raquel Delgado et al.
CANCERS (2021)
CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism
Matteo Grioni et al.
BLOOD ADVANCES (2021)
NF-κB signaling in inflammation and cancer
Tao Zhang et al.
MEDCOMM (2021)
Interleukin-1 receptor-associated kinase 4 inhibitor interrupts toll-like receptor signalling and sensitizes chronic lymphocytic leukaemia cells to apoptosis
Vincenza Simona Delvecchio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?
Philipp M. Roessner et al.
LEUKEMIA (2020)
Small Molecule NF-κB Pathway Inhibitors in Clinic
Venkataramanan Ramadass et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
B cell signalling pathways-New targets for precision medicine in chronic lymphocytic leukaemia
Sigrid S. Skanland et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia
Claudia Tandler et al.
CANCERS (2020)
Modeling the Leukemia Microenviroment In Vitro
Cristina Scielzo et al.
FRONTIERS IN ONCOLOGY (2020)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Hui Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α
Marilena Pontoriero et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Substrate complex competition is a regulatory motif that allows NFκB RelA to license but not amplify NFκB RelB
Simon Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib
Eman L. Dadashian et al.
CANCER RESEARCH (2019)
Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling
Man Nie et al.
CLINICAL CANCER RESEARCH (2019)
BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation
Daniela Asslaber et al.
CLINICAL CANCER RESEARCH (2019)
Prognostic Significance of Serum BAFF, APRIL, TACI and BCMA Levels in Chronic Lymphocytic Leukemia
Ilay Berke Mentese et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2019)
CUDC-907 blocks multiple pro-survival signals and abrogates microenvironment protection in CLL
Yixiang Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib
Emily M. McWilliams et al.
BLOOD ADVANCES (2019)
Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia
Carl Philipp Simon-Gabriel et al.
HAEMATOLOGICA (2018)
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways
D. Benedetti et al.
LEUKEMIA (2018)
Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia
Carl Philipp Simon-Gabriel et al.
HAEMATOLOGICA (2018)
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
James D. Phelan et al.
NATURE (2018)
The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies
Francesca Arruga et al.
FRONTIERS IN ONCOLOGY (2018)
CD73, CD90, CD105 and Cadherin-11 RT-PCR Screening for Mesenchymal Stem Cells from Cryopreserved Human Cord Tissue
Hung Pham et al.
INTERNATIONAL JOURNAL OF STEM CELLS (2018)
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components
F. Pozzo et al.
LEUKEMIA (2017)
MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene
Shu-Chao Qin et al.
BLOOD CANCER JOURNAL (2017)
The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages
Lingyan Ping et al.
ONCOTARGET (2017)
Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL
Kallesh D. Jayappa et al.
BLOOD ADVANCES (2017)
NF-κB in Hematological Malignancies
Veronique Imbert et al.
BIOMEDICINES (2017)
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib - Findings from an Investigator-Initiated Phase II Study
Carsten U. Niemann et al.
CLINICAL CANCER RESEARCH (2016)
Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
Anna Parente-Ribes et al.
HAEMATOLOGICA (2016)
BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia
S-S Chen et al.
LEUKEMIA (2016)
Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
Anna Parente-Ribes et al.
HAEMATOLOGICA (2016)
IL-4 rescues surface IgM expression in chronic lymphocytic leukemia
Benchang Guo et al.
BLOOD (2016)
High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
Sina Oppermann et al.
BLOOD (2016)
Noncanonical NF-κB Signaling in Health and Disease
Goekhan Cildir et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Resistance to ABT-199 induced by microenvironmental signals in chronic iymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors
Rachel Thijssen et al.
HAEMATOLOGICA (2015)
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Larry Mansouri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia
Zhen-Shu Xu et al.
ONCOLOGY REPORTS (2015)
Resistance to ABT-199 induced by microenvironmental signals in chronic iymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors
Rachel Thijssen et al.
HAEMATOLOGICA (2015)
B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells
Vaclav Seda et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation
Arantza Onaindia et al.
HAEMATOLOGICA (2015)
Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia
Li Jia et al.
BLOOD (2014)
Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib
Dominik Wodarz et al.
BLOOD (2014)
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia
F. Arruga et al.
LEUKEMIA (2014)
Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
Kristina Heinig et al.
CANCER DISCOVERY (2014)
Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients
Frederik Damm et al.
CANCER DISCOVERY (2014)
A Pathway Switch Directs BAFF Signaling to Distinct NFκB Transcription Factors in Maturing and Proliferating B Cells
Jonathan V. Almaden et al.
CELL REPORTS (2014)
Non-canonical NF-κB signaling initiated by BAFF influences B cell biology at multiple junctures
Sandra Gardam et al.
FRONTIERS IN IMMUNOLOGY (2014)
IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells
Maria Fernanda Pascutti et al.
BLOOD (2013)
In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors
Eleonora Fonte et al.
CLINICAL CANCER RESEARCH (2013)
Follicular dendritic cells: origin, function, and different disease-associated patterns
Sherif A. Rezk et al.
HUMAN PATHOLOGY (2013)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells
Stefania Fiorcari et al.
PLOS ONE (2013)
Study of the Quantitative, Functional, Cytogenetic, and Immunoregulatory Properties of Bone Marrow Mesenchymal Stem Cells in Patients with B-Cell Chronic Lymphocytic Leukemia
Charalampos Pontikoglou et al.
STEM CELLS AND DEVELOPMENT (2013)
B cell receptor signaling in chronic lymphocytic leukemia
Jan A. Burger et al.
TRENDS IN IMMUNOLOGY (2013)
Regulation of nuclear factor-κB in autoimmunity
Shao-Cong Sun et al.
TRENDS IN IMMUNOLOGY (2013)
Chronic Lymphocytic Leukemia Cells Are Activated and Proliferate in Response to Specific T Helper Cells
Audun Os et al.
CELL REPORTS (2013)
CD40-mediated activation of the NF-kappa B2 pathway
Bruce S. Hostager et al.
FRONTIERS IN IMMUNOLOGY (2013)
The B-cell receptor signaling pathway as a therapeutic target in CLL
Jennifer A. Woyach et al.
BLOOD (2012)
Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells
Emma Hamilton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
Marcus Duehren-von Minden et al.
NATURE (2012)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
Giulia Fabbri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
CD40 stimulation sensitizes CLL cells to rituximab-induced cell death
M. Jak et al.
LEUKEMIA (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Stereotypical Chronic Lymphocytic Leukemia B-Cell Receptors Recognize Survival Promoting Antigens on Stromal Cells
Mascha Binder et al.
PLOS ONE (2010)
Controlling the Fate of NIK: A Central Stage in Noncanonical NF-κB Signaling
Shao-Cong Sun
SCIENCE SIGNALING (2010)
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Jan A. Burger et al.
BLOOD (2009)
Chronic lymphocytic leukemia of Eμ-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression
Thomas Enzler et al.
BLOOD (2009)
Expression and function of toll like receptors in chronic lymphocytic leukaemia cells
Marta Muzio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
NF-κB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia
Chris Pepper et al.
FUTURE ONCOLOGY (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Crosstalk via the NF-κB signaling system
Soumen Basak et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Novel insights in chronic lymphocytic leukemia: Are we getting closer to understanding the pathogenesis of the disease?
Federico Caligaris-Cappio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Generation and activation of multiple dimeric transcription factors within the NF-κB signaling system
Soumen Basak et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
IL-4-stimulated NF-κB activity is required for Stat6 DNA binding
Vivian T. Thieu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathway
Tomoyuki Endo et al.
BLOOD (2007)
Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells
Cindy Grandjenette et al.
HAEMATOLOGICA (2007)
Transcriptional regulation via the NF-κB signaling module
A. Hoffmann et al.
ONCOGENE (2006)
BAFF, APRIL and their receptors: Structure, function and signaling
Claudia Bossen et al.
SEMINARS IN IMMUNOLOGY (2006)
Targeting NF-κB in hematologic malignancies
T Braun et al.
CELL DEATH AND DIFFERENTIATION (2006)
Notch1 augments NF-κB activity by facilitating its nuclear retention
HM Shin et al.
EMBO JOURNAL (2006)
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α
M Nishio et al.
BLOOD (2005)
Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL
B He et al.
JOURNAL OF IMMUNOLOGY (2004)
A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells
S Cuní et al.
LEUKEMIA (2004)
CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack
AP Kater et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Leucine-rich repeats and pathogen recognition in Toll-like receptors
JK Bell et al.
TRENDS IN IMMUNOLOGY (2003)
CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes
L Granziero et al.
BLOOD (2003)
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
EA Leadbetter et al.
NATURE (2002)
Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells
RR Furman et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
